Dechra's global headquarters is relocating to the US

Veterinary pharmaceutical company Dechra is relocating its global headquarters to Boston, Massachusetts, from Northwich, England. The move repositions the company’s executive leadership and strategic operations and reflects its’ investment in a growing North American market, according to Dechra.

The new headquarters is expected to be operational by June 2026. The facility will reflect Dechra’s goal to accelerate growth in veterinary specialty care. The company cited Boston’s life sciences ecosystem, deep talent pool, and global connectivity with making it a strategic location for the business.

“As a pioneer in life sciences and innovation, Boston represents an exciting new chapter for Dechra,” Jesper Nordengaard, CEO of Dechra, said in a news release. “Our new headquarters will serve as a center of gravity for strategic decision-making and purposeful collaboration. The [location] strengthens our ability to collaborate across markets, connect with partners and customers, and unlock our full growth potential.”

Situated in Boston’s seaport district, the 28,000+ square foot headquarters will be designed as a state-of-the-art technology enabled collaboration hub, according to Dechra. The space will support the company’s remote-first operating model that promotes both work schedule and location flexibility. Although the majority of employees will continue to work remotely or in hybrid arrangements, the Boston headquarters will anchor global meetings, while supporting cross-functional collaboration and innovation initiatives.

“Massachusetts is the global hub for life sciences innovation, and Dechra’s decision to establish its global headquarters in Boston is another powerful example of why companies choose to grow here,” Massachusetts Governor Maura Healey, said in the release. “Our world-class research institutions, talented workforce, and collaborative innovation ecosystem create the ideal environment for companies advancing breakthroughs in health and science. We are proud to welcome Dechra’s leadership to Boston and look forward to supporting their continued growth.”

As part of its’ transition, Dechra plans to consolidate its existing US offices in Kansas City, Kansas, and Portland, Maine. Office transitions will occur in phases to ensure continuity of operations and support for employees.

“Dechra’s decision to locate its global headquarters in Boston underscores Massachusetts’ leadership in life sciences and our ability to attract companies at the forefront of innovation. Boston offers a unique combination of talent, industry partnerships, and global connectivity that allows companies to scale and collaborate,” Eric Paley, secretary of Massachusetts Economic Development,said the news release. “As a state full of caring pet owners, it’s especially fitting to welcome a company dedicated to keeping our dogs, cats, and other companions healthy. We’re excited to welcome Dechra to Massachusetts and look forward to supporting its work to advance veterinary specialty care and animal health worldwide.”

In the United Kingdom, Dechra is proposing to consolidate its Northwich and Sansaw offices. A new office in Manchester will serve as a key collaboration hub for the company’s European and International operations, including some corporate functions. Additional details are expected to be announced by Dechra later in 2026.

Reference

Dechra to establish global headquarters in Boston. News release. Dechra. March 11, 2026. Accessed March 11, 2026. https://www.dechra.com/news/2026/march/dechra-to-establish-global-headquarters-in-boston